Venture Capital Funding, Partnership Deal Structures to be Addressed at Medical Device Corporate Strategy Conference

Online, October 17, 2014 (Newswire.com) - As the medical device industry continues to grow despite increased regulatory hurdles and depleted federal funding, business development professionals face an increasing amount of challenges. At the Medical Device Corporate Strategy and Business Development Conference, senior level executives will gather to discuss the most top of mind trends, best practices, and hurdles, offering attendees a plethora of networking opportunities and implementable ideas.

The conference, hosted by Q1 Productions, will be held February 23-24, 2015 in Dallas, Texas, and will offer perspectives from all corners of the medical device industry, such as small and large companies, companies currently in the midst of an acquisition, and the legal space. Some of the industry’s most experienced professionals will be leading sessions, case studies and panel discussions, including Jim Mooney of Steris Corporation, Vera Imper of Becton Dickinson, and Mark Domyahn of St. Jude Medical. Topics addressed include regulatory and reimbursement challenges, overcoming realistic valuation expectations, and corporate strategy surrounding mergers and acquisitions.

One of the largest mergers is currently underway, as Medtronic has begun the process of buying Covidien and attendees of the conference will have the opportunity to discuss corporate strategy surrounding mergers and acquisitions with Derek Devgun of Medtronic. Devgun will provide insight on identifying the best candidates, understanding the importance of tax inversion, and structuring successful deals.  

For more information on the Medical Device Corporate Strategy and Business Development Conference, or any of Q1 Productions’ upcoming conferences, please visit www.q1productions.com/business-development. You can also follow Q1 Productions on Twitter, @Q1Productions, #BizDev15.